Komipharm International Co. Ltd (041960) — Cash Flow-to-Debt Ratio
Komipharm International Co. Ltd (041960) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of ₩946.94 Million could theoretically repay 0% of its total liabilities (₩61.86 Billion) in one year. See cash generation quality of Komipharm International Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Komipharm International Co. Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Komipharm International Co. Ltd across 13 annual periods. Also explore 041960 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Komipharm International Co. Ltd (2013–2025)
Year-by-year debt coverage analysis for Komipharm International Co. Ltd. For market capitalisation and broader financial context, see Komipharm International Co. Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | ₩-621.80 Million | ₩61.86 Billion | ▼ -106.5% |
| 2024 | 0.15x | ₩8.85 Billion | ₩57.23 Billion | ▲ +423.5% |
| 2023 | -0.05x | ₩-2.80 Billion | ₩58.58 Billion | ▼ -35.1% |
| 2022 | -0.04x | ₩-1.81 Billion | ₩51.12 Billion | ▼ -37.4% |
| 2021 | -0.03x | ₩-1.26 Billion | ₩48.80 Billion | ▼ -4760.6% |
| 2020 | 0.00x | ₩25.20 Million | ₩45.64 Billion | ▼ -97.0% |
| 2019 | 0.02x | ₩950.79 Million | ₩52.37 Billion | ▲ +141.9% |
| 2018 | -0.04x | ₩-2.02 Billion | ₩46.52 Billion | ▼ -983.6% |
| 2017 | 0.00x | ₩235.64 Million | ₩48.00 Billion | ▼ -77.0% |
| 2016 | 0.02x | ₩1.21 Billion | ₩56.64 Billion | ▲ +141.7% |
| 2015 | -0.05x | ₩-2.93 Billion | ₩57.26 Billion | ▼ -43.7% |
| 2014 | -0.04x | ₩-2.54 Billion | ₩71.24 Billion | ▼ -158.0% |
| 2013 | 0.06x | ₩3.93 Billion | ₩64.08 Billion | — |